Nebulized Lidocaine and Intranasal Midazolam for NGT Insertion in Children
Clinical trial NCT04571879 · UNKNOWN
Trial details
- NCT number
- NCT04571879
- Sponsor
- Hamad Medical Corporation
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-25
- Primary completion
- 2023-12-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.